Does the media prefer CELC or GH?

In the previous week, Celcuity had 17 more articles in the media than Guardant Health. MarketBeat recorded 34 mentions for Celcuity and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.45 beat Celcuity's score of -0.09 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 7 Very Negative mention(s) Neutral Guardant Health 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor BTSG or CELC?

In the previous week, Celcuity had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Celcuity and 18 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.73 beat Celcuity's score of -0.09 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 7 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 7 Very Negative mention(s) Neutral

Does the media refer more to CELC or FMS?

In the previous week, Celcuity had 32 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 34 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.71 beat Celcuity's score of -0.09 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 7 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to CELC or HIMS?

In the previous week, Celcuity had 17 more articles in the media than Hims & Hers Health. MarketBeat recorded 34 mentions for Celcuity and 17 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.92 beat Celcuity's score of -0.09 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 7 Very Negative mention(s) Neutral Hims & Hers Health 10 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, PACS or CELC?

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.04 $191.54M $1.56 22.30 Celcuity N/A N/A -$177.04M -$3.90 N/A

Is PACS or CELC more profitable?

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.49% 26.47% 4.36% Celcuity N/A -244.61% -50.22%

Does the media prefer PACS or CELC?

In the previous week, Celcuity had 33 more articles in the media than PACS Group. MarketBeat recorded 34 mentions for Celcuity and 1 mentions for PACS Group. Celcuity's average media sentiment score of -0.09 beat PACS Group's score of -0.35 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Celcuity 7 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 7 Very Negative mention(s) Neutral

Celcuity (CELC) Competitors

$90.18 +2.75 (+3.15%)

As of 12:24 PM Eastern

Compare

CELC vs. GH, BTSG, FMS, HIMS, and PACS

Should you buy Celcuity stock or one of its competitors? MarketBeat compares Celcuity with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Celcuity include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Celcuity compare to Guardant Health?

Celcuity (NASDAQ:CELC) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Celcuity has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Guardant Health	$982.02M	16.77	-$416.28M	-$3.39	N/A

Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Guardant Health	-40.10%	N/A	-26.42%

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market.

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 13.3% of Celcuity shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Celcuity had 17 more articles in the media than Guardant Health. MarketBeat recorded 34 mentions for Celcuity and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.45 beat Celcuity's score of -0.09 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	7 Very Negative mention(s)	Neutral
Guardant Health	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Celcuity currently has a consensus target price of $152.09, suggesting a potential upside of 68.65%. Guardant Health has a consensus target price of $139.80, suggesting a potential upside of 12.59%. Given Celcuity's higher probable upside, research analysts plainly believe Celcuity is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	20 Buy rating(s)	1 Strong Buy rating(s)	2.95

Summary

Guardant Health beats Celcuity on 10 of the 16 factors compared between the two stocks.

How does Celcuity compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

BrightSpring Health Services has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market.

BrightSpring Health Services has a net margin of 2.27% compared to Celcuity's net margin of 0.00%. BrightSpring Health Services' return on equity of 14.63% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Celcuity	N/A	-244.61%	-50.22%

In the previous week, Celcuity had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 34 mentions for Celcuity and 18 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.73 beat Celcuity's score of -0.09 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	7 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	7 Very Negative mention(s)	Neutral

63.3% of Celcuity shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

BrightSpring Health Services has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$13.65B	0.86	$190.67M	$1.41	42.09
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

BrightSpring Health Services currently has a consensus target price of $58.53, suggesting a potential downside of 1.38%. Celcuity has a consensus target price of $152.09, suggesting a potential upside of 68.65%. Given Celcuity's higher possible upside, analysts clearly believe Celcuity is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Summary

BrightSpring Health Services beats Celcuity on 12 of the 16 factors compared between the two stocks.

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Celcuity (NASDAQ:CELC) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment.

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.74

In the previous week, Celcuity had 32 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 34 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.71 beat Celcuity's score of -0.09 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	7 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

63.3% of Celcuity shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Celcuity currently has a consensus target price of $152.09, suggesting a potential upside of 68.65%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, suggesting a potential upside of 25.48%. Given Celcuity's stronger consensus rating and higher possible upside, equities analysts plainly believe Celcuity is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Celcuity compare to Hims & Hers Health?

Celcuity (NASDAQ:CELC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

Celcuity presently has a consensus target price of $152.09, indicating a potential upside of 68.65%. Hims & Hers Health has a consensus target price of $28.70, indicating a potential upside of 9.08%. Given Celcuity's stronger consensus rating and higher possible upside, equities research analysts plainly believe Celcuity is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12

In the previous week, Celcuity had 17 more articles in the media than Hims & Hers Health. MarketBeat recorded 34 mentions for Celcuity and 17 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.92 beat Celcuity's score of -0.09 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	7 Very Negative mention(s)	Neutral
Hims & Hers Health	10 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has higher revenue and earnings than Celcuity. Hims & Hers Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Hims & Hers Health	$2.35B	2.59	$128.37M	-$0.09	N/A

Celcuity has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Hims & Hers Health	-0.56%	6.10%	1.52%

63.3% of Celcuity shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Celcuity has a beta of 0.1, indicating that its share price is 90% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its share price is 137% more volatile than the broader market.

Summary

Hims & Hers Health beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Celcuity compare to PACS Group?

PACS Group (NYSE:PACS) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

PACS Group presently has a consensus price target of $48.00, indicating a potential upside of 37.97%. Celcuity has a consensus price target of $152.09, indicating a potential upside of 68.65%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

PACS Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.04	$191.54M	$1.56	22.30
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

In the previous week, Celcuity had 33 more articles in the media than PACS Group. MarketBeat recorded 34 mentions for Celcuity and 1 mentions for PACS Group. Celcuity's average media sentiment score of -0.09 beat PACS Group's score of -0.35 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Celcuity	7 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	7 Very Negative mention(s)	Neutral

63.3% of Celcuity shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 13.3% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

PACS Group has a net margin of 4.49% compared to Celcuity's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Celcuity	N/A	-244.61%	-50.22%

Summary

PACS Group beats Celcuity on 8 of the 14 factors compared between the two stocks.

Get Celcuity News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CELC vs. The Competition

Export

Metric	Celcuity	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.39B	$3.29B	$6.45B	$11.84B
Dividend Yield	N/A	2.31%	2.67%	5.58%
P/E Ratio	-23.10	18.98	23.86	23.56
Price / Sales	N/A	300.48	530.02	114.80
Price / Cash	N/A	51.45	26.99	37.25
Price / Book	41.56	8.00	10.56	6.66
Net Income	-$177.04M	$23.89M	$3.56B	$337.25M
7 Day Performance	-1.36%	-3.94%	-1.58%	-2.53%
1 Month Performance	-31.19%	1.74%	0.85%	1.33%
1 Year Performance	598.53%	35.08%	20.08%	23.50%

Celcuity Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CELC Celcuity	3.0534 of 5 stars	$90.18 +3.1%	$152.09 +68.7%	+570.0%	$4.39B	N/A	N/A	40
GH Guardant Health	2.4226 of 5 stars	$129.53 -0.1%	$136.37 +5.3%	+159.9%	$17.20B	$1.08B	N/A	2,506	Analyst Forecast Insider Trade
BTSG BrightSpring Health Services	4.0116 of 5 stars	$60.25 -2.3%	$57.64 -4.3%	+145.6%	$11.96B	$12.91B	42.56	23,500	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.8521 of 5 stars	$20.97 -2.8%	$28.00 +33.5%	-23.6%	$11.65B	$19.36B	11.03	1,488
HIMS Hims & Hers Health	3.1815 of 5 stars	$27.53 +5.3%	$28.70 +4.2%	-52.0%	$6.43B	$2.37B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CELC) was last updated on 6/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Celcuity (CELC) Competitors

CELC vs. GH, BTSG, FMS, HIMS, and PACS

How does Celcuity compare to Guardant Health?

Summary

How does Celcuity compare to BrightSpring Health Services?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Celcuity compare to Hims & Hers Health?

Summary

How does Celcuity compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Celcuity (CELC) Competitors

CELC vs. GH, BTSG, FMS, HIMS, and PACS

How does Celcuity compare to Guardant Health?

Which has better valuation & earnings, CELC or GH?

Is CELC or GH more profitable?

Which has more volatility & risk, CELC or GH?

Do insiders & institutionals hold more shares of CELC or GH?

Does the media prefer CELC or GH?

Do analysts recommend CELC or GH?

Summary

How does Celcuity compare to BrightSpring Health Services?

Which has more volatility and risk, BTSG or CELC?

Is BTSG or CELC more profitable?

Does the media favor BTSG or CELC?

Do institutionals & insiders hold more shares of BTSG or CELC?

Which has higher valuation & earnings, BTSG or CELC?

Do analysts prefer BTSG or CELC?

Summary

How does Celcuity compare to Fresenius Medical Care AG & Co. KGaA?

Which has more volatility & risk, CELC or FMS?

Which has better earnings and valuation, CELC or FMS?

Does the media refer more to CELC or FMS?

Is CELC or FMS more profitable?

Do institutionals and insiders hold more shares of CELC or FMS?

Do analysts prefer CELC or FMS?

Summary

How does Celcuity compare to Hims & Hers Health?

Do analysts rate CELC or HIMS?

Does the media refer more to CELC or HIMS?

Which has stronger earnings and valuation, CELC or HIMS?

Is CELC or HIMS more profitable?

Do institutionals & insiders have more ownership in CELC or HIMS?

Which has more risk and volatility, CELC or HIMS?

Summary

How does Celcuity compare to PACS Group?

Do analysts prefer PACS or CELC?

Which has higher valuation and earnings, PACS or CELC?

Does the media prefer PACS or CELC?

Do insiders and institutionals believe in PACS or CELC?

Is PACS or CELC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CELC vs. The Competition

Celcuity Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools